CCL19 enhances CD8+ T-cell responses and accelerates HBV clearance

被引：0
作者：
Yan Yan
Wei Zhao
Wei Liu
Yan Li
Xu Wang
Jingna Xun
Chantsalmaa Davgadorj
机构：
[1] Affiliated Hospital of Jiangnan University,Laboratory for Infection and Immunity, The Fifth People’s Hospital of Wuxi
[2] Affiliated Hospital of Jiangnan University,Hepatology Institute of Wuxi, The Fifth People’s Hospital of Wuxi
[3] Medical School of Nanjing University,The State Key Laboratory of Pharmaceutical Biotechnology, Chemistry and Biomedicine Innovation Center, Model Animal Research Center
[4] Fudan University,Shanghai Public Health Clinical Center
来源：
Journal of Gastroenterology | 2021年 / 56卷
关键词：
Chemokine (C–C motif) ligand 19 (CCL19); Hepatitis B virus; CD8; T cell; Apoptosis; Regulatory T cell (T; cell);
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：769 / 785
页数：16
相关论文
共 50 条
  • [1] CCL19 enhances CD8+ T-cell responses and accelerates HBV clearance
    Yan, Yan
    Zhao, Wei
    Liu, Wei
    Li, Yan
    Wang, Xu
    Xun, Jingna
    Davgadorj, Chantsalmaa
    JOURNAL OF GASTROENTEROLOGY, 2021, 56 (08) : 769 - 785
  • [2] How are HBV-specific CD8+ T-cell responses induced?
    Isogawa, Masanori
    Murata, Yasuhiro
    Kawashima, Keigo
    Tanaka, Yasuhito
    FUTURE VIROLOGY, 2018, 13 (12) : 825 - 827
  • [3] Pre-Activation of Toll-Like Receptor 2 Enhances CD8+ T-Cell Responses and Accelerates Hepatitis B Virus Clearance in the Mouse Models
    Lin, Yong
    Huang, Xuan
    Wu, Jun
    Liu, Jia
    Chen, Mingfa
    Ma, Zhiyong
    Zhang, Ejuan
    Liu, Yan
    Huang, Shunmei
    Li, Qian
    Zhang, Xiaoyong
    Hou, Jinlin
    Yang, Dongliang
    Lu, Mengji
    Xu, Yang
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [4] Serum HBsAg clearance has minimal impact on CD8+ T cell responses in mouse models of HBV infection
    Fumagalli, Valeria
    Di Lucia, Pietro
    Venzin, Valentina
    Bono, Elisa B.
    Jordan, Robert
    Frey, Christian R.
    Delaney, William
    Chisari, Francis, V
    Guidotti, Luca G.
    Iannacone, Matteo
    JOURNAL OF EXPERIMENTAL MEDICINE, 2020, 217 (11)
  • [5] HBV-Derived Synthetic Long Peptide Can Boost CD4+ and CD8+ T-Cell Responses in Chronic HBV Patients Ex Vivo
    Dou, Yingying
    van Montfoort, Nadine
    van den Bosch, Aniek
    de Man, Robert A.
    Zom, Gijs G.
    Krebber, Willem-Jan
    Melief, Cornelis J. M.
    Buschow, Sonja I.
    Woltman, Andrea M.
    JOURNAL OF INFECTIOUS DISEASES, 2018, 217 (05) : 827 - 839
  • [6] The CD8+ T Cell Noncytotoxic Antiviral Responses
    Morvan, Maelig G.
    Teque, Fernando C.
    Locher, Christopher P.
    Levy, Jay A.
    MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS, 2021, 85 (02)
  • [7] Hepatic effector CD8+ T-cell dynamics
    Matteo Iannacone
    Cellular & Molecular Immunology, 2015, 12 : 269 - 272
  • [8] CD8+ T-cell senescence: no role for mTOR
    Henson, Sian M.
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2015, 43 : 734 - 739
  • [9] Hepatic effector CD8+ T-cell dynamics
    Iannacone, Matteo
    CELLULAR & MOLECULAR IMMUNOLOGY, 2015, 12 (03) : 269 - 272
  • [10] Perpetual complexity: predicting human CD8+ T-cell responses to pathogenic peptides
    Di Carluccio, Anthony R.
    Triffon, Cristina F.
    Chen, Weisan
    IMMUNOLOGY AND CELL BIOLOGY, 2018, 96 (04) : 358 - 369
12345